Healthcare Services

Global Gastrointestinal Pathogen Testing Market Set for Strong Expansion Reaching $5.06 Billion by 2030 at 3.5% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Gastrointestinal Pathogen Testing Market By The End Of 2030?

The gastrointestinal pathogen testing market size has experienced consistent expansion in recent years. This market is projected to increase from $4.23 billion in 2025 to $4.41 billion in 2026, showing a compound annual growth rate (CAGR) of 4.2%. The historical growth can be attributed to the high prevalence of gastrointestinal infections, the adoption of culture-based testing, hospital laboratory expansion, foodborne illness outbreaks, and public health surveillance programs.

The gastrointestinal pathogen testing market is projected to experience consistent expansion in the coming years. It is anticipated to reach $5.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.5%. This expansion during the projection period stems from factors such as the increasing use of syndromic testing panels, broader availability of point-of-care diagnostics, a need for quicker results, the incorporation of molecular diagnostics, and heightened awareness regarding infectious diseases. Significant developments anticipated within this timeframe encompass the increasing deployment of multiplex molecular diagnostic panels, a greater need for rapid stool testing, the proliferation of point-of-care GI diagnostics, an uptick in the adoption of PCR-based testing, and a stronger emphasis on monitoring infections.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Gastrointestinal Pathogen Testing Market?

The increasing occurrence of foodborne illnesses is projected to boost the expansion of the gastrointestinal pathogen testing market. These diseases originate from consuming food or beverages tainted with harmful microorganisms, toxins, or chemical agents, encompassing conditions such as listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The escalation in foodborne incidents stems from various factors, including evolving patterns in food production, distribution, and consumption, insufficient food safety protocols, and the impacts of climate change on food systems. Gastrointestinal testing plays a crucial role in pinpointing the exact pathogens responsible for these illnesses, enabling healthcare providers to identify symptom causes, prescribe suitable treatments, monitor outbreaks, and implement preventative measures to curb the spread of foodborne diseases. For example, in September 2025, the Centers for Disease Control and Prevention (CDC), a US federal public health agency, reported that in 2023, the CDC, in collaboration with state and regulatory public health partners, looked into 181 potential multistate outbreaks; 84 of these were confirmed as outbreaks. Of these, investigators successfully resolved 50 outbreaks, representing 60%. A potential source was identified for 22 outbreaks, with a definitive source confirmed for 28. Consequently, the rising frequency of foodborne diseases is acting as a significant catalyst for the gastrointestinal pathogen testing market’s growth.

Which Segment Classifications Shape The Gastrointestinal Pathogen Testing Market?

The gastrointestinal pathogen testing market covered in this report is segmented –

1) By Pathogen Type: Bacteria, Viruses, Parasites

2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types

3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types

4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users

Subsegments:

1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens

2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens

3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens

What Trends Are Projected To Affect The Gastrointestinal Pathogen Testing Market?

Leading companies within the gastrointestinal pathogen testing market are concentrating on developing advanced solutions, such as metagenomic diagnostic tests, to improve the precision, rapidity, and broadness of identifying gastrointestinal pathogens. A metagenomic diagnostic test represents a cutting-edge technology that examines the genetic makeup of microorganisms found in samples like stool or blood. For instance, in April 2024, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel, a metagenomic diagnostic test designed to identify a wide range of gastrointestinal pathogens with unparalleled accuracy. MetaPanel is capable of identifying 175 pathogen targets from a single sample, providing healthcare professionals with an all-encompassing tool for diagnosing both prevalent and challenging-to-find infections. It utilizes next-generation sequencing (NGS) technology to examine a diverse array of genetic material present in a stool sample. This methodology enables the identification of numerous potential pathogens, including those typically overlooked by traditional GI (gastrointestinal) panels.

Which Companies Are Expanding Their Footprint In The Gastrointestinal Pathogen Testing Market?

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

Read the full gastrointestinal pathogen testing market report here:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Which Regions Are Projected To Dominate The Gastrointestinal Pathogen Testing Market In The Coming Years?

North America was the largest region in the gastrointestinal pathogen testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gastrointestinal Pathogen Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Pathogen Testing Market 2026, By The Business Research Company

Capsule Endoscopy System Global Market Report

https://www.thebusinessresearchcompany.com/report/capsule-endoscopy-system-global-market-report

Endoscopic Ultrasound Global Market Report

https://www.thebusinessresearchcompany.com/report/endoscopic-ultrasound-global-market-report

Endoscopy Devices And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/endoscopy-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795